10.1016/j.cmet.2012.06.015 37 GrillH
Total protein amounts were detected in parallel by the BCA assay (Pierce BCA Protein assay Kit) for normalization of glutathione levels
No pharmacy runs
It works through nitric oxide modulation, VEGF-driven angiogenesis, and the FAK-paxillin cell migration pathway
As per the regulators Complete Response Letter, the FDA asked for additional evidence to confirm the efficacy and safety of glepaglutide at its proposed dose and recommended that Zealand run another clinical trial to generate these data
SGLT2 Inhibitors The EMPA-REG OUTCOME and CANVAS studies have shown favourable all-cause mortality and cardiovascular outcomes.11,12 Meta-analyses of CVOTs confirmed the cardiovascular benefits.17,18 Three studies from landmark CVOTs further stratified patients according to baseline characteristics.21,22,23 The benefits of SGLT2 inhibitors were more apparent in patients with a history of HF and reduced ejection fraction.22,23 However, baseline risk was higher in this group of patients, possibly accounting for higher absolute risk reductions in cardiovascular outcomes